Dear friends of the University of Miami Miller School of Medicine,

What a remarkable start to the year for our community!

First and foremost, please join me in celebrating a transformative, $50 million donation from philanthropist and businessman Kenneth C. Griffin to Sylvester Comprehensive Cancer Center, part of the Miller School of Medicine. This generous gift will propel groundbreaking therapies and advance unparalleled care for those affected by cancer.

Furthermore, I am delighted to share that several of our departments surged in the 2023 Blue Ridge Institute for Medical Research rankings, which are based on National Institutes of Health funding. We remain Florida’s No. 1 medical school for federal research grants and seven of our programs are ranked among the top 25 nationally.

Our success extends to the medical education realm, as well. The Class of 2024 recently achieved a remarkable 100% placement rate in the residency placement process and will soon be joining top-tier programs here and across the country. This outcome is a testament to their commitment and hard work, as well as the unparalleled education they received as #MedCanes.

I would be remiss not to express my deepest gratitude to our generous donors whose support sustains our mission and propels our initiatives forward. Several of their stories can be found in this issue. Their generosity improves the lives of countless individuals, and we are profoundly thankful for their commitment to our shared vision.

Additionally, I want to take a moment to laud the achievements of our successful alumni, whose exemplary leadership and dedication to excellence inspire us all. We were delighted to see many of them at the recent 2024 Medical Alumni Weekend.

There are countless other exciting developments taking place at the Miller School and I urge you to delve into this edition of University of Miami Medicine to read about AI and simulation technology, gene editing and so much more. Together, we are truly transforming the future of medicine.